Document:

<PAGE>   1

                                                                   EXHIBIT 10.12

                     MANAGING DIRECTOR EMPLOYMENT AGREEMENT
                     --------------------------------------

                  THIS MANAGING DIRECTOR EMPLOYMENT AGREEMENT (the "Contract")
is made and effective as of the date indicated below by and between

DataTRAK Deutschland GmbH, Am Probsthof 80, 53121 Bonn  (the "Company")

and

Dr. Wolfgang Summa, Endenicher Allee 124, 53121 Bonn.

                                   WITNESSETH:
                                   -----------

                   WHEREAS, based on his employment contract dated January 13,
1998, Dr. Summa is employed with the Company since January 1, 1998, as Manager
Operations; and

                   WHEREAS, since the parties entered into the employment
contract dated January 13, 1998, the nature and scope of Dr. Summa's
responsibilities has changed; and

                   WHEREAS, by shareholders' resolution of February 23, 1999,
Dr. Summa was appointed as Managing Director (Geschaftsfuhrer) of the Company
with sole signatory power; and

                   WHEREAS, the Company and Dr. Summa desire to terminate the
employment contract dated January 13, 1998, and enter into an agreement
expressly indicating the new terms and conditions of their relationship.

                   NOW, THEREFORE, in consideration of the mutual promises and
covenants contained herein, the Company and the Dr. Summa agree as follows:

                  1. DUTIES AND REPRESENTATION. The Company employs Dr. Summa as
Managing Director (Geschaftsfuhrer). Dr. Summa shall perform his duties in
accordance with the instructions of the shareholders' meeting and in compliance
with this managing director employment contract (the "Contract"), the Articles
of Association of the Company and the applicable legal provisions.

                  1.1 PERFORMANCE OF DUTIES. During the Term of this Contract,
as those terms are defined herein, Dr. Summa shall at all times, faithfully,
industriously and to the best of his abilities, perform all duties that
reasonably may be required of him by virtue of his position. Dr. Summa shall
devote his full business time and efforts to the affairs of the Company. Dr.
Summa shall require the prior written approval of the shareholders' meeting for
any compensated or

                                       1
<PAGE>   2

uncompensated side activities (Nebentatigkeit). This shall also apply for
positions on a supervisory board, advisory board or similar boards.

                     1.2 REPRESENTATION. Dr. Summa shall be entitled to
represent the Company alone. However, Dr. Summa must always comply with the
applicable DataTRAK internal control procedures and practices.

Notwithstanding the approval requirements pursuant to the Articles of
Association, Dr. Summa shall require the prior written approval of the
shareholders' meeting for the following transactions, unless they have already
been approved by the shareholders' meeting in the annual budget:

      -    the granting and revocation (unless in case of imminent danger)
           of Prokura or other general Powers of Attorney,

      -    any measure which significantly changes the structure of the Company
           or outside the object of the Company, including the cessation of
           existing lines of business and areas of business activity of the
           Company,

      -    the sale of the Company in whole or essential parts thereof,

      -    the acquisition, sale or encumbrance of participations in other
           companies in whole or in part,

      -    the establishment, closure, sale or relocation of subsidiaries and
           branches,

      -    the entering into any joint venture or partnership agreement and the
           exercise of voting rights conferred by virtue of participation in
           another company, partnership or other organization,

      -    the purchase, encumbrance or sale of real estate or similar rights
           as well as any obligatory  contracts related thereto,

      -    the erection of new or major change of existing buildings belonging
           to the Company,

      -    the conclusion, termination or amendment of customer contracts (in
           particular Clinical Trial Projects) having an aggregate financial
           exposure of more than DM 500,000 per contract,

      -    the conclusion, termination or amendment of employee contracts having
           a term of more than one year and an aggregate financial exposure of
           more than DM 100,000,

      -    the conclusion, termination or amendment of any other contract with
           an aggregate exposure of more than DM 50,000,

      -    the assuming of guarantees or warranties (except customary product
           warranties), the assuming or granting of loans of any kind outside
           the customary payment requirements of suppliers and customers,

                                       2
<PAGE>   3

      -    the conclusion, termination or amendment of existing agreements with
           banks or credit institutions,

      -    the granting of loans to employees,

      -    the formation or acquisition of trademarks, trade names or licenses,

      -    all  transactions which exceed the limits of the annual budget of the
           Company as approved by the shareholders' meeting,

      -    the conclusion, amendment or termination of employment contracts with
           Prokuristen or other executive employees,

      -    the granting of participation rights on turnover and profit as well
           as the granting of boni in excess of the DataTRAK bonus plan approved
           by the shareholders' meeting,

      -    the establishment and change of non-budgeted remuneration and/or
           pension payments to employees of the Company,

      -    the introduction of new, fundamental changes or the cessation of
           existing product groups, fundamental changes of the internal
           organisation or the wage and salary policy as well as other
           fundamental strategic decisions that relate to the sales program,
           sales activities, etc.,

      -    the pledging or mortgaging of any asset of the Company,

      -    the issuing or acceptance of bills of trade,

      -    the instigation or resolution of legal actions (including arbitration
           proceedings) to which the Company is a party with an exposure of more
           than DM 200,000,

      -    any waiver of claims exceeding DM 20,000, and

      -    any other measure, action or decision which may have a material
           impact on the business of the Company.

                   2. SALARY. The Company will pay Dr. Summa a base salary of DM
210,000 (two hundred ten thousand Deutsche Mark per year in accordance with the
Company's payroll practices, or in such other periodic method to which both
parties agree, minus statutory withholdings and deductions. The Company will
review Dr. Summa's compensation hereunder on an annual basis, and may adjust the
above-indicated level, in its sole discretion, based on Dr. Summa's performance
of his duties hereunder and/or the performance of the Company, provided,
however, that the Company shall not reduce Dr. Summa's salary to be paid in any
succeeding year to an amount less than Dr. Summa's base salary as established
herein or as increased over time without Dr. Summa's written agreement. Both
parties agree that the above reference to an "annual base salary" or to other
benefits of employment, including but not limited to bonuses, does not in any
way guarantee and/or add to the express

                                       3
<PAGE>   4

length of employment of Dr. Summa, other than as set forth herein.

                    3. BONUS PLANS. The Company may pay Dr. Summa additional
compensation in the form of a discretionary bonus and/or pursuant to an
established bonus plan(s) that the Company or DataTRAK International Inc. may
have in effect from time to time for similarly situated employees. The Company
reserves the right to modify or cancel any bonus plan(s) that it may have in
effect at any given time. The Company will be obligated to pay all amounts
earned and due to Dr. Summa prior to the modification or cancellation of any
established bonus plans. The bonus may be paid in cash, in equity securities of
DataTRAK International Inc., in stock options, or in any combination thereof at
the Company's discretion.

                    4. STOCK OPTION PLAN. Dr. Summa shall be eligible to
participate in any stock option plans that the Company or DataTRAK International
Inc. may make available from time to time for similarly situated employees. The
granting of stock options will be pursuant to the terms and conditions of a
separate Stock Option Agreement.

                    5. BENEFITS. During the Term of this Contract, Dr. Summa
shall be entitled to participate in any employment benefit plans and/or
retirement plans which are maintained or established by the Company for its
similarly situated employees, including enrollment in medical, dental, and life
insurance policies or plans, as well as a 401K plan, and all paid holidays
afforded to other similarly situated employees. Additionally, Dr. Summa is
entitled to capital accumulation benefits (Vermogenswirksame Leistungen) in the
amount of DM 936.00 (nine-hundred-thirty-six Deutsche Mark) per year. These
benefits are granted in addition to his salary as provided in Section 2.

                   6. RESERVATION OF VOLUNTARINESS. Any and all payments in kind
and any and all payments in cash as gratification, bonus, profit sharing or any
other benefits provided in addition to the base salary according to Section 2
are discretionary benefits by the Company and establish no right to such claims
in the future. However, this does not apply for the capital accumulation
benefits as mentioned in Section 5.

                    7. COMPANY CAR. The Company will provide Dr. Summa with a
company car which he is also entitled to use for private purposes. Type and
purchase price will be determined by the shareholders' meeting. The current
allowance is DM 7,800 p.a. (This Allowance is in addition to Dr. Summa's salary
as stated in section 2.) All taxes arising out of the private use as well as
expenditures for private travels shall be borne by Dr. Summa. The Company is
entitled to demand the return of the company car at the end of Dr. Summa's
employment or in case of Dr. Summa's suspension. Until further notice, the
vehicle [Audi A6] with the license plate number BN-DT440 remains at Dr. Summa's
disposal as his company car.

                    8. VACATIONS. During the Term of this Contract, Dr. Summa
shall be entitled to annual paid vacation time equal to thirty (30) days, to
be taken at a time or times acceptable to the Company and otherwise consistent
with the terms and conditions of this Contract and the Company's vacation pay
policy.

                                       4
<PAGE>   5

                   9. RELOCATION EXPENSES. The Company is entitled to transfer
Dr. Summa to a different employment location outside of Bonn. During the Term of
this Contract, if Dr. Summa is required by the Company to relocate his permanent
residence to a location outside of [North-Rhine-Westphalia/Germany], then the
Company will reimburse Dr. Summa for all reasonable relocation expenses,
including the expense of moving Dr. Summa's possessions and reasonable expenses
incurred in travel to the new location for the purpose of locating housing. The
Company will further reimburse Dr. Summa for all reasonable temporary housing
expenses at the new location for the first 90 days after the date requested by
the Company for Dr. Summa's relocation.

                           9.1 REAL ESTATE BROKER'S COMMISSIONS. The Company
will reimburse Dr. Summa for reasonable licensed real estate broker's commission
(Broker's Fee) incurred by Dr. Summa in the sale of Dr. Summa's permanent
residence if Dr. Summa is required by the Company to relocate his permanent
residence to a location outside of [North-Rhine-Westphalia/Germany]. Dr. Summa
will provide the Company with appropriate documentation to support the Broker's
Fee incurred by Dr. Summa.

                           10. TERM AND TERMINATION OF AGREEMENT. This Contract
shall commence on the date signed by both parties as indicated below and shall
continue for a period of one (1) year (the "Initial Term"), unless sooner
terminated as provided in paragraphs 10.1, 10.2, 10.3, 10.5, 10.6, 10.7 or 10.8
of this Contract. This Contract will renew automatically for successive one (1)
year periods (the "Renewal Period," and collectively with the Initial Term, the
"Term") unless previously terminated or either party gives notice of non-renewal
at least 90 days prior to the commencement of such Renewal Period.

                           10.1 TERMINATION FOR DEATH. This Contract shall
terminate automatically upon the Dr. Summa's death. With the exception of any
benefits under the Company's employee benefit plans, and any stock options that
have vested under the Company's Stock Option Plan(s) which may inure to the
benefit of Dr. Summa's beneficiaries upon Dr. Summa's death, the Company shall
have no further obligations under the terms and conditions of this Contract. If
Dr. Summa's employment is terminated pursuant to this section during the Term of
this Contract, Dr. Summa's heirs shall be entitled to his salary through the
date of such termination, payment for any pro-rata bonus earned and due at the
time of termination pursuant to any (if any) bonus plan(s) the Company may have
in effect at the time of termination, and to any other employee benefits
maintained or established by the Company for its similarly situated employees.

                           10.2 TERMINATION FOR DISABILITY. The Company and Dr.
Summa acknowledge and agree that the essential functions of the Dr. Summa's
position are unique and critical to the Company and that a disability condition
which causes the Dr. Summa to be unable to perform the essential functions of
his position with or without reasonable accommodations for a period in excess of
one hundred twenty (120) calendar days will constitute an undue hardship on the
Company. If the Company determines in good faith upon medical certification and
in consultation with Dr. Summa and, if necessary or appropriate, with Dr.
Summa's physician(s), that Dr. Summa is disabled and unable to perform the
essential function of his position with or without reasonable accommodations, it
may give Dr. Summa written notice of its intention to terminate Dr. Summa's
employment. If Dr. Summa's employ

                                       5
<PAGE>   6

ment is terminated pursuant to this section during the Term of this Contract,
Dr. Summa shall be entitled to his salary through the date of such termination,
payment for any pro-rata bonus earned and due at the time of termination
pursuant to any (if any) bonus plans the Company may have in effect at the time
of termination, and to any other employee benefits maintained or established by
the Company for its similarly situated employees.

                           10.3 TERMINATION BY COMPANY FOR CAUSE. During the
Term of this Contract, the Company may terminate Dr. Summa's employment for
cause by written notification citing the specific reasons for termination. For
purposes of this Contract, "Cause" means in particular (without being limited
thereto):

                                    (1) Dr. Summa's conviction of a felony
involving moral turpitude or a felony in connection with his employment;

                                    (2) Dr. Summa's theft, fraud, embezzlement,
material willful destruction of property or material disruption of the
operations of the Company;

                                    (3) Dr. Summa's use or possession of illegal
drugs and/or unauthorized use of significant amounts of alcohol on Company
premises or reporting to work under the influence of same; or

                                    (4) Dr. Summa's engaging in conduct, in or
out of the workplace, which in the Company's reasonable determination has an
adverse effect on the reputation or business of the Company.

Under any such termination for Cause, all rights, benefits, obligation and
duties of the parties hereunder shall immediately cease, except any compensation
due and owing through the date of termination and/or fringe benefits which have
vested on Dr. Summa's behalf prior to such termination, if any.

                           10.4 SUSPENSION. In the event Dr. Summa engages in
conduct subjecting Dr. Summa to potential civil or criminal liability which
could have an adverse effect upon the Company's reputation or business or is
related to Dr. Summa's duties and responsibilities, the Company reserves the
right to immediately suspend Dr. Summa with pay, pending investigation and/or
the outcome of the matter.

Additionally, the Company at any time shall have the right to suspend Dr. Summa
in the event of any termination of this Contract by either party, regardless for
which reason, until the expiration of the Contract.

                           10.5 TERMINATION BY DR. SUMMA WITHOUT GOOD
REASON/NON-RENEWAL BY DR. SUMMA. During the Term of this Contract, Dr. Summa may
terminate his employment and this Contract at any time for any or no reason upon
at least 30 days written notice by Dr. Summa directly to the shareholders of the
Company. Prior to and/or during any Renewal Period, Dr. Summa may also terminate
this Contract by giving a notice of non-renewal at least 120 days prior to the
commencement of the next Renewal Period. Dr. Summa acknowledges and agrees that
a voluntary resignation, termination or retirement by Dr.

                                       6
<PAGE>   7

Summa during the Term of this Contract as described in this Section 10.5, and/or
a notice of non-renewal prior to and/or during any Renewal Period as described
in this Section 10.5, shall result in the termination of this Contract and all
rights and obligations under this Contract shall immediately cease upon the
expiration of the Contract, except any fringe benefits or stock options which
have vested on Dr. Summa's behalf prior to such expiration and - for the
avoidance of doubt - except for the rights and obligations according to Section
11.

                           10.6 TERMINATION BY DR. SUMMA FOR GOOD REASON. Dr.
Summa may terminate his employment and this Contract at any time during the Term
of this Contract for "Good Reason." "Good Reason" shall mean any fundamental
breach of contract by the Company, including but not limited to (a) any material
reduction by the Company of Dr. Summa's duties, responsibilities, base salary,
title or position, or (b) any involuntary removal of Dr. Summa from any position
previously held (except in connection with a promotion or a termination for
Cause, Death, or Disability, or the voluntary termination by Dr. Summa without
Good Reason). Prior to any termination by Dr. Summa for Good Reason pursuant to
this Section 10.6, Dr. Summa shall provide the Company with sixty (60) calendar
days' written notice of the acts and/or omissions of the Company which Dr. Summa
asserts constitute "Good Reason," and if, at the conclusion of that sixty (60)
calendar day period, the Company has not undertaken reasonable efforts to cure
or correct the alleged acts and/or omissions, then Dr. Summa may terminate his
employment pursuant to this Section 10.6. In the event of such termination by
Dr. Summa for Good Reason, Dr. Summa shall be entitled to receive (i) his salary
through the date of the expiration of the Contract and for a period of one (1)
year after such expiration, and (ii) outplacement services from an agency to be
selected by the Company in an amount not to exceed Ten Thousand (US$10,000)
US-Dollars or the equivalent thereof in Deutsche Mark or EURO.

                           10.7 TERMINATION OTHER THAN FOR CAUSE, DEATH, OR
DISABILITY/NON-RENEWAL BY COMPANY. During the Term of this Contract, the Company
may terminate Dr. Summa for other than Cause, Death, or Disability at any time
during the Term and/or any Renewal Term of this Contract, upon not less than
thirty (30) days notice. Prior to and/or during any Renewal Period, the Company
may also terminate this Contract by giving a notice of non-renewal at least 120
days prior to the commencement of the next Renewal Period. In the event the
Company exercises its right to terminate Dr. Summa other than for Cause, Death,
or Disability at any time during the Term of this Contract as described in this
Section 10.7, and/or gives a notice of non-renewal prior to and/or during any
Renewal Period as described in this Section 10.7, Dr. Summa shall at the time of
the expiration of the Contract be entitled to receive (i) his salary through the
date of such expiration of the Contract and for a period of one (1) year after
such expiration, and (ii) outplacement services from an agency to be selected by
the Company in an amount not to exceed Ten Thousand (US$10,000) US-Dollars or
the equivalent thereof in Deutsche Mark or EURO.

                           10.8 CHANGE OF CONTROL. If a Change of Control (as
defined in this paragraph) shall occur during the Term of this Contract, and Dr.
Summa's employment is (a) not continued by the purchaser or successor or (b)
there is a material change in Dr. Summa's role, duties, responsibility or title
following a Change of Control and Dr. Summa voluntarily terminates his
employment and this Contract therefor, Dr. Summa shall be entitled to receive
(i) his salary through the date of such non-continuation and for a period of one
(1) year after

                                       7
<PAGE>   8

such non-continuation, and (ii) outplacement services from an agency to be
selected by the Company in an amount not to exceed Ten Thousand (US$10,000)
US-Dollars or the equivalent thereof in Deutsche Mark or EURO. For purposes
hereof, the term "Change of Control" shall mean (A) the sale of all or
substantially all of the assets of the Company, (B) the sale of a majority of
the outstanding shares of capital stock of the Company entitled to vote in a
single transaction or series of related transactions (except with respect to a
public offering of the Company's shares of capital stock), (C) the consummation
of a merger, consolidation or similar transaction involving the Company in which
the holders of the Company's capital stock immediately prior to the transaction
do not retain at least a majority of the voting power of the Company surviving
the merger or its parent Company, or (D) the complete liquidation or dissolution
of the Company.

                           10.9 RESIGNATION FROM OFFICES. In case of a
termination of this Contract, for whatever reason, Dr. Summa shall resign with
immediate effect from all positions on supervisory or similar boards that have
been transferred to him with respect to his position as Managing Director of the
Company.

                           10.10 DISPUTE RESOLUTION. In the event, upon
termination of Dr Summa's employment, a disagreement exists between Dr. Summa
and the Company as to the validity of the termination or as to which section of
this Section 10 governs such termination (i.e., if the party terminating Dr.
Summa's employment (the "Terminating Party") claims that "Cause", "Good Reason",
"Disability" or "Change of Control" exists and the other party (the "Disputing
Party") disputes such claim), the Disputing Party shall within thirty (30) days
after termination of Dr. Summa's employment challenge the claimed basis for
termination by giving written notice (the "Dispute Notice") of such challenge to
the Terminating Party. In the event the Disputing party fails to give the
Dispute Notice within the thirty (30) day period provided above, all rights of
the Disputing Party to challenge the claimed basis for termination shall expire.

                            11.0 RESTRICTIVE COVENANTS OF DR. SUMMA.

                            11.1    NON-COMPETITION.

                                    (1) During the period of Dr. Summa's
employment by the Company and, (i) in the case of the termination of Dr. Summa's
employment under Sections 10.2, 10.6, 10.7, or 10.8 hereof, for a period of one
(1) year thereafter, or (ii) in the case of the termination of Dr. Summa's
employment under any provision of Section 10 hereof other than Sections 10.2,
10.6, 10.7, or 10.8 for a period of eighteen (18) months (the "Non-competition
Period"), Dr. Summa shall not, directly or indirectly, whether as an individual
on his own account, or as a partner, joint venturer, director, officer,
employee, consultant, creditor and/or agent or otherwise, in any place in which
the Company now or hereafter conducts business:

                                             (a) Enter into or engage in any
business which provides software and related web hosting, educational and
training services, and/or other Applications Services Provider ("ASP") services,
to customers in the pharmaceutical, biotech, and/or medical device industries to
assist in the electronic capture of clinical trial patient data from clinical
trial sites;

                                       8
<PAGE>   9

                                             (b) Solicit customers, business,
patronage or orders from, or perform other services for, any person, firm,
association, corporation or other entity, engaged in any business, including
without limitation, an Applications Services Provider, which directly or
indirectly competes with the business of the Company or any parent or subsidiary
of, or entity controlling, controlled by or under common control with the
Company ("Company Affiliate"); or

                                             (c) Promote or assist, financially
or otherwise, any person, firm, association, corporation or other entity,
engaged in any business, including without limitation, an Applications Services
Provider, which competes with the current or future business of the Company or
any Company Affiliate; provided, however, that the foregoing covenant shall not
be deemed to have been violated solely by (i) the ownership of equity securities
of an entity which competes with a future business of the Company or any Company
Affiliate, to the extent that such securities are acquired prior to the date
that the Company or Company Affiliate commences such future business; or (ii)
the ownership for investment purposes of less than five percent (5%) of the
equity securities of any entity which has equity securities listed on a national
securities exchange or publicly traded in the over-the-counter market.

                                    (2) Dr. Summa, however, is allowed to work
as an employee or as a consultant for pharmaceutical, biotech, and/or medical
device companies as long as his activities do not have a negative impact on the
Company's business with its customers (ref. to Section 11.3).

                                    (3) For the time period after the expiration
of the Contract, the competition prohibition according to this Section 11 is
limited to the territory of Germany.

                                    (4) As compensation for the non competition
obligation for the time period after the expiration of the Contract, during such
time frame the Company shall be obligated to pay to Dr. Summa on a monthly basis
50% of the gross average remuneration Dr. Summa was entitled to prior the
expiration of the Contract ("Previous Remuneration") in accordance with Section
74b sub-section (2) of the German Commercial Code (HGB). Such compensation shall
be due at the end of each respective month.

Any and all benefits (including any payments by the Company Dr. Summa is
entitled to under this Contract after its expiration) earned by Dr. Summa during
the term of the post-contractual non-competition obligation by utilizing his
working capacity as well as any and all benefits not earned due to malicious
intent shall be credited to the compensation due to the extent that such
benefits and the compensation would exceed the Previous Remuneration by 1/10,
respectively 1/4 in the event Dr. Summa changes his residence based on this
post-contractual non competition obligation.

                                    (5) During the post-contractual
non-competition period, Dr. Summa shall be obligated to supply to the Company by
the end of each calendar quarter, or at any other time at the Company's written
request, information as to the benefits earned and the names and addresses of
his respective employers. He shall furthermore, at the Company's request,
furnish evidence thereof.

                                       9
<PAGE>   10

                                    (6) Unemployment benefits
("ARBEITSLOSENGELD") will be deducted from any payment due under this Section
11.

                                    (7) Section 75a of the German Commercial
Code shall apply.

                           11.2 CONFIDENTIALITY AND WORK PRODUCT. Dr. Summa
acknowledges that during his employment with the Company he has had and will
have access to confidential information, knowledge, and data regarding the
business of the Company and Company Affiliates, whether received, acquired or
developed by him or otherwise, including, without limitation, trade secrets,
design information, software programs, research methods and techniques,
scientific data and formulae, pricing data, customer information and all other
information or data relevant to the business of the Company (collectively,
except any of the foregoing which is at the time generally known to the public
and which did not become generally known through the breach of any agreement
restricting its disclosure, "Proprietary Information"). Dr. Summa further
acknowledges that in the course of his employment he may be producing designs,
analyses, recommendations, reports, complications, software, studies and other
worth product, acquiring information on behalf of the Company and any conceive
of ideas, innovations, processes and improvements relating to the business of
the Company (collectively, "Work Product"). As to the ownership, disclosure and
use of Proprietary Information and Work Product, Dr. Summa agrees that, from and
after the date hereof:

                           (a) he will promptly disclose in writing to the
Company all Work Product;

                           (b) all Proprietary Information, all Work Product and
all rights therein are and shall be the sole and exclusive property of the
Company (to the extent this is not possible for legal reasons, the Company shall
have the exclusive and comprehensive right to use such Proprietary Information
and/or Work Product) and all rights or interest of Dr. Summa therein are covered
by the remuneration according to Section 2 of this Contract and are hereby
assigned by Dr. Summa to the Company, and Dr. Summa will cooperate with and
assist the Company from time to time, in any manner reasonably requested by the
Company, in obtaining title or ownership therein or evidence thereof;

                           (c) Dr. Summa shall not divulge, disclose or
communicate to any third party in any manner, directly or indirectly,
Proprietary Information or Work Product; this applies during and upon expiration
of this Contract;

                           (d) Dr. Summa will not use, during or upon expiration
of this Contract, for his own benefit or purposes or for the benefit or purposes
of any third party or permit or assist, by acquiescence or otherwise, any third
party to use in any manner, directly or indirectly, Proprietary Information or
Work Product; and

                           (e) upon the expiration of the Contract, Dr. Summa
will promptly deliver to the Company all Proprietary Information and Work
Product, including, without limitation, any reproductions, copies, abstracts,
summaries or other documents or records of

                                       10
<PAGE>   11

Proprietary Information or Work Product.

                           11.3 NO INTERFERENCE. During the Non-competition
Period, Dr. Summa agrees that he shall not:

                                    (a) interfere with the contractual
relationship of the Company, any Company Affiliate, customers, suppliers,
employees or other which relate to the business of the Company or any Company
Affiliate; or

                                    (b) induce any employee or representative of
the Company or any Company Affiliate not to continue as an employee or
representative of the Company or any Company Affiliate;

                                    (c) make remarks or take any other action
which disparages or diminishes the reputation of the Company or any Company
Affiliate; and

                                    (d) without limiting the generality of the
foregoing, without the prior written consent of the shareholders' meeting of the
Company, directly or indirectly employ, whether as an employee, officer,
director, agent, consultant or independent contractor, any person who was an
employee, representative, officer or director of the Company or any Company
Affiliate at any time during the six-month period prior to the date of such
proposed employment; provided, however, that the covenants contained in this
clause (d) shall not apply with respect to such person terminated by action of
the Company or any Company Affiliate.

                           11.4 INJUNCTIVE RELIEF. Both parties hereto recognize
that the services to be rendered by Dr. Summa to the Company are special, unique
and of extraordinary character, that the market for the Company's services and
products is worldwide; that through the Internet, World Wide Web, and/or other
media of electronic commerce, the Company regularly transacts business
worldwide; and that if Dr. Summa hereafter fails to comply with the restrictions
and obligations imposed upon him hereunder, the Company may not have an adequate
remedy at law. Accordingly, the Company, in addition to any other rights, which
it may have, shall be entitled to seek injunctive relief to enforce such
restrictions and obligations without the necessity of posting any bond.

                  12. REPRESENTATIONS OF DR. SUMMA. Dr. Summa represents and
warrants to the Company that he has the capacity to enter into this Contract
that he is not a party to any agreement, arrangement or other understanding with
any person or entity which might affect, restrain or conflict with the
provisions of this Contract and/or the services to be provided to the Company by
Dr. Summa under this Contract.

                                       11
<PAGE>   12

                    13. PRECLUSIVE TIME LIMIT Any and all alleged claims under
this Contract must be asserted by the respective party vis-a-vis the other party
within three (3) months after obtaining knowledge of the facts constituting the
claim, or, in case of salary or bonus claims, since receipt of the respective
pay-slip. In the event of non-compliance with the above period of three (3)
months, all such claims are deemed to be waived. Section 10.10 remains
unaffected.

                   14. REFORMATION OF AGREEMENT; SEVERABILITY. In the event that
any provision or term of this Contract is found to be void or unenforceable to
any extent for any reason, it is the agreed-upon intent of the parties hereto
that all remaining provisions or terms of the Contract shall remain in full
force and effect to the maximum extent permitted and that the Contract shall be
enforceable as if such void or unenforceable provision or term had never been a
part hereof.

                   15. ASSIGNMENT. This Contract shall inure to the benefit of,
and shall be binding upon, the Company, its successors and assigns. Dr. Summa
shall not assign this Contract without the prior written consent of the Company.

                   16. NOTICE. Any notice required to be given under the terms
of this Contract shall be in writing, and mailed to the recipient's last known
address or delivered in person. If sent by registered or certified mail, such
notice shall be effective when mailed; otherwise, it shall be effective upon
delivery.

                    17. ENTIRE AGREEMENT; AMENDMENTS: WAIVERS. This Contract
contains the entire agreement between the parties hereto with respect to the
subject matter hereof. This Contract may not be validly changed orally, but only
by agreement, in writing, signed by each of the parties hereto. The terms or
covenants of this Contract, including this provision, may be waived only by a
written instrument specifically referring to this Contract, executed by the
party waiving compliance. The failure of the Company at any time, or from time
to time, to require performance of any of Dr. Summa's obligations under this
Contract shall in no manner affect the Company's right to enforce any provisions
of this Contract at a subsequent time; and the waiver by the Company of any
right arising out of any breach shall not be construed as a waiver of any right
arising out of any subsequent breach.

                    18. HEADINGS. The headings in this Contract are intended
solely for convenience of reference and shall be given no effect in the
construction or interpretation of this Contract.

                    19. COUNTERPARTS. This Contract may be executed in multiple
counterparts each of which shall be deemed an original but all of which together
shall constitute one and the same document.

                    20. PREVIOUS EMPLOYMENT AGREEMENT. The parties hereby
terminate Dr. Summa's employment contract dated January 13, 1998 with effect to
the commencement of this Contract.

                    21. GENERAL PROVISIONS. This Contract shall be governed by
and con-

                                       12
<PAGE>   13

strued in accordance with the laws of Germany.

                   IN WITNESS WHEREOF, the parties hereto have executed this
Contract as of the dates written below.

Date:  December 29, 2000              /s/ Wolfgang Summa
       --------------------------     ------------------------------
                                      DR. WOLFGANG SUMMA

                                      DataTRAK DEUTSCHLAND GmbH

Date  December 29, 2000               By  /s/ Jeffrey A. Green
      ---------------------------     -------------------------
                                      Title: Chief Executive Officer and
                                      President of DataTRAK International Inc.).

                                       13<PAGE>   1

                                                                    Exhibit 10.6

                                 RES-CARE, INC.

                             401(K) RESTORATION PLAN

                                   Prepared By

                                  Alan Parsons

                                       and

                               Margaret Handmaker

                                 (502) 561-4500

                         William M. Mercer, Incorporated
                              1500 Meidinger Tower
                              Louisville, KY 40202

                                December 5, 1995

<PAGE>   2

                                 RES-CARE, INC.

                                TABLE OF CONTENTS
                                -----------------

<TABLE>
<CAPTION>
   ARTICLE     SECTION                                                       PAGE
   -------     -------                                                       ----
<S>              <C>     <C>                                                   <C>
      I                  PURPOSE AND EFFECTIVE DATE .........................  1
                 1.01    Title...............................................  1
                 1.02    Purpose.............................................  1
                 1.03    Effective Date......................................  1

     II                  DEFINITIONS AND CONSTRUCTION OF THE PLAN DOCUMENT...  2
                 2.01    Annual Deferral Amount..............................  2
                 2.02    Beneficiary.........................................  2
                 2.03    Board...............................................  2
                 2.04    Bookkeeping Account Balance.........................  2
                 2.05    Code................................................  2
                 2.06    Committee...........................................  2
                 2.07    Company.............................................  2
                 2.08    Company Contribution................................  2
                 2.09    Compensation........................................  3
                 2.10    Crediting Rate......................................  3
                 2.11    Deferred Compensation...............................  3
                 2.12    Disabled............................................  3
                 2.13    Election Date.......................................  3
                 2.14    Election Form.......................................  3
                 2.15    Employee............................................  3
                 2.16    Participant.........................................  3
                 2.17    Plan................................................  4
                 2.18    Plan Administrator..................................  4
                 2.19    Plan Year...........................................  4
                 2.20    Qualified Plan......................................  4
                 2.21    Termination of Employment...........................  4
                 2.22    Unforeseeable Financial Emergency...................  4
                 2.23    Valuation Date......................................  4
                 2.24    Gender and Number...................................  4
                 2.25    Titles..............................................  4
</TABLE>

<PAGE>   3

                                TABLE OF CONTENTS
                                -----------------

                                   (Continued)
                                   -----------

<TABLE>
<CAPTION>
   ARTICLE     SECTION                                                       PAGE
   -------     -------                                                       ----
<S>              <C>     <C>                                                   <C>

     III                 ELIGIBILITY AND PARTICIPATION.......................  5
                 3.01    Eligibility.........................................  5
                 3.02    Participation.......................................  5

     IV                  PARTICIPANT DEFERRALS OF COMPENSATION AND COMPANY
                         MATCHING CONTRIBUTIONS..............................  6
                 4.01    Deferred Compensation...............................  6
                 4.02    Company Contribution................................  6
                 4.03    Vesting.............................................  6
                 4.04    Duration of Election Form...........................  7
                 4.05    Election to Modify or Terminate Future Contributions  7

     V                   DEFERRAL ACCOUNT AND CREDITING RATE.................  8
                 5.01    Bookkeeping Account.................................  8
                 5.02    Interest............................................  8

     VI                  DISTRIBUTION........................................  9
                 6.01    Distribution of Bookkeeping Account Balance.........  9
                 6.02    Form of Distribution................................  9
                 6.03    Timing of Distribution..............................  9
                 6.04    Death Prior to Commencement of Benefit Payments.....  9
                 6.05    Death of a Participant Subsequent to Commencement
                         of Installment Payments.............................  9

     VII                 UNFORESEEABLE FINANCIAL EMERGENCY...................  10
                 7.01    Unforeseeable Financial Emergency...................  10
</TABLE>

<PAGE>   4

                                TABLE OF CONTENTS
                                -----------------

                                   (Continued)
                                   -----------

<TABLE>
<CAPTION>
   ARTICLE     SECTION                                                       PAGE
   -------     -------                                                       ----
<S>              <C>     <C>                                                   <C>
     VIII                BENEFICIARY.......................................... 11
                 8.01    Beneficiary Designation.............................. 11
                 8.02    Proper Beneficiary................................... 11
                 8.03    Minor or Incompetent Beneficiary..................... 11
                 8.04    No Beneficiary Designation........................... 11

     IX                  ADMINISTRATION OF THE PLAN........................... 12
                 9.01    Majority Vote........................................ 12
                 9.02    Finality of Determination............................ 12
                 9.03    Certificates and Reports............................. 12
                 9.04    Indemnification and Exculpation...................... 12
                 9.05    Expenses............................................. 13
                 9.06    FICA and Other Taxes................................. 13

     X                   CLAIMS PROCEDURE..................................... 14
                 10.01   Written Claim........................................ 14
                 10.02   Denied Claim......................................... 14
                 10.03   Review Procedure..................................... 14
                 10.04   Committee Review..................................... 14

     XI                  NATURE OF COMPANY'S OBLIGATION....................... 15
                 11.01   Company's Obligation................................. 15
                 11.02   Creditor Status...................................... 15

     XII                 MISCELLANEOUS........................................ 16
                 12.01   Written Notice....................................... 16
                 12.02   Change of Address.................................... 16
                 12.03   Merger, Consolidation or Acquisition................. 16
                 12.04   Amendment and Termination............................ 16
</TABLE>

<PAGE>   5

                                TABLE OF CONTENTS
                                -----------------

                                   (Continued)
                                   -----------

<TABLE>
<CAPTION>
   ARTICLE     SECTION                                                       PAGE
   -------     -------                                                       ----
<S>              <C>     <C>                                                   <C>
                12.05    Employment........................................... 16
                12.06    Non-transferability.................................. 16
                12.07    Legal Fees........................................... 17
                12.08    Tax Withholding...................................... 17
                12.09    Acceleration of Payment.............................. 17
                12.10    Applicable Law....................................... 17
</TABLE>

<PAGE>   6

                                    ARTICLE I

                           PURPOSE AND EFFECTIVE DATE
                           --------------------------

         1.01 TITLE. This Plan shall be known as Res-Care, Inc. 401(k)
Restoration Plan (hereinafter referred to as the "Plan").

         1.02 PURPOSE. The purpose of the Plan is to permit certain members of
management or highly compensated employees to defer Compensation pre-tax without
regard to the limits imposed by the Internal Revenue Code on tax-qualified
savings and retirement plans. The Plan constitutes an unfunded "top hat"
arrangement under Title I of ERISA as well as for income tax purposes.

         1.03 EFFECTIVE DATE. The effective date of this Plan shall be
December 1, 1995.

                                       1
<PAGE>   7

                                   ARTICLE II

                 DEFINITIONS AND CONSTRUCTION OF THE PLAN DOCUMENT
                 -------------------------------------------------

         2.01 ANNUAL DEFERRAL AMOUNT. "Annual Deferral Amount" shall mean that
portion of a Participant's Compensation to be paid during a Plan Year that a
Participant elects to have and is deferred for any one Plan Year. In the event
of a Participant's Termination of Employment prior to the end of a Plan Year,
such year's Annual Deferral Amount shall be the actual amount deferred and
withheld prior to such event.

         2.02 BENEFICIARY. "Beneficiary" shall mean the person or persons or the
estate of a Participant entitled to receive any benefits under this Plan in the
event of the Participant's death.

         2.03 BOARD. "Board" shall mean the Board of Directors of the Company.

         2.04 BOOKKEEPING ACCOUNT BALANCE. "Bookkeeping Account Balance" shall
mean with respect to a Participant the sum of (i) his or her Deferred
Compensation, plus (ii) his or her Company Contributions, plus (iii) interest
credited in accordance with all the applicable interest crediting provisions of
this Plan, less (iv) all distributions. This account shall be a bookkeeping
entry only and shall be utilized solely as a device for the measurement and
determination of the amounts to be paid to a Participant pursuant to this Plan.

         2.05 CODE. "Code" shall mean the Internal Revenue Code of 1986, as may
be amended from time to time.

         2.06 COMMITTEE. "Committee" means the Executive Committee of the Board
of Directors.

         2.07 COMPANY. "Company" shall mean Res-Care, Inc. and any subsidiary or
affiliated companies that adopt the Plan, with the Company's approval, for its
Employees.

         2.08 COMPANY CONTRIBUTION. "Company Contribution" shall mean the
amounts credited to the Participant's Bookkeeping Account Balance under Section
4.02 of the Plan.

         2.09 COMPENSATION. "Compensation" shall have the same meaning as
provided in the Qualified Plan (without regard to any limitations imposed by the
Code and without regard to any deferrals made under the terms of this Plan).

                                       2
<PAGE>   8

         2.10 CREDITING RATE. "Crediting Rate" shall mean, starting December 1,
1995 and for each Plan Year starting thereafter, an interest rate determined and
announced by the Committee that is equal to 110% of the Moody's Rate. The
Moody's Rate for a Plan Year shall be the interest rate that (i) is published in
Moody's Bond Record under the heading of "Moody's Corporate Bond Yield Averages
-- Baa Corp.," and (ii) is equal to the average corporate bond yield published
for the calendar year which precedes the Plan Year for which the rate is to be
used.

         2.11 DEFERRED COMPENSATION. "Deferred Compensation" shall mean the sum
of all of a Participant's Annual Deferral Amounts.

         2.12 DISABLED. "Disabled" shall mean Total and Permanent Disability
under the terms of the Company's long-term disability plan in effect at the time
of such determination of Disability.

         2.13 ELECTION DATE. "Election Date" shall mean the date established by
the Committee as the date before which an Employee must submit a valid Election
Form to the Plan Administrator. The applicable Election Dates can be no later
than the following: (a) 30 days after adoption of the Plan for Employees who are
eligible to participate at the time the Plan is adopted, (b) 30 days after a
newly eligible Employee is notified of the right to participate in the Plan, or
(c) December 15 prior to an applicable Plan Year if (a) or (b) above do not
apply.

         2.14 ELECTION FORM. "Election Form" shall mean the form established
from time to time by the Committee that a Participant completes, signs and
returns to the Plan Administrator to make an election under the Plan.

         2.15 EMPLOYEE. "Employee" shall mean any member of management or highly
compensated employee who is eligible to participate in the Plan.

         2.16 PARTICIPANT. "Participant" shall mean an Employee who has Deferred
Compensation pursuant to the terms of this Plan, and whose Bookkeeping Account
balance has not yet been fully distributed.

                                       3
<PAGE>   9

         2.17 PLAN. "Plan" shall mean the Res-Care, Inc. 401(k) Restoration Plan
as described in this instrument and as amended from time to time.

         2.18 PLAN ADMINISTRATOR. "Plan Administrator" shall mean the Retirement
Plan Committee of the Company.

         2.19 PLAN YEAR. "Plan Year" shall mean a calendar year.

         2.20 QUALIFIED PLAN. "Qualified Plan" shall mean the Res-Care, Inc.
Retirement Savings Plan as in effect at the date of the adoption of this Plan
and as amended from time to time.

         2.21 TERMINATION OF EMPLOYMENT. "Termination of Employment" or similar
expression shall mean the termination of the Participant's employment as a
employee of the Company and any division, subsidiary or affiliate thereof. A
Disabled Participant shall be deemed to have terminated employment for purposes
of this Plan.

         2.22 UNFORESEEABLE FINANCIAL EMERGENCY. "Unforeseeable Financial
Emergency" shall mean an unanticipated emergency that is caused by an event
beyond the control of the Participant that would result in severe financial
hardship to the Participant resulting from (i) a sudden and unexpected illness
or accident of the Participant or a dependent of the Participant, (ii) a loss of
the Participant's property due to casualty, or (iii) such other extraordinary
and unforeseeable circumstances arising as a result of events beyond the control
of the Participant, all as determined in the sole discretion of the Committee.

         2.23 VALUATION DATE. "Valuation Date" shall mean the last day of each
calendar quarter.

         2.24 GENDER AND NUMBER. Wherever the context so requires, masculine
pronouns include the feminine and singular words shall include the plural.

         2.25 TITLES. Titles of the Articles of this Plan are included for ease
of reference only and are not to be used for the purpose of construing any
portion or provision of this Plan document.

                                       4
<PAGE>   10

                                   ARTICLE III

                          ELIGIBILITY AND PARTICIPATION
                          -----------------------------

         3.01 ELIGIBILITY. Eligibility for participation in this Plan shall be
determined by the Committee, in its sole discretion, but all Participants must
be a member of a select group of management or highly-compensated employees of
the Company and must be eligible to participate in the Qualified Plan.

         3.02 PARTICIPATION. An Employee, after having been selected for
participation by the Committee, shall, as a condition to participation, complete
and return to the Plan Administrator a duly executed Election Form no later than
the applicable Election Date. A Bookkeeping Account will be established for each
Participant at the time an Election Form is received by the Plan Administrator.

                                       5
<PAGE>   11

                                   ARTICLE IV

                      PARTICIPANT DEFERRALS OF COMPENSATION
                      -------------------------------------
                       AND COMPANY MATCHING CONTRIBUTIONS
                       ----------------------------------

         4.01 DEFERRED COMPENSATION. Each Participant in the Plan may have a
percentage of Compensation deferred in accordance with the terms and conditions
of this Plan. The percentage of such Compensation to be deferred each pay period
under this section shall be any whole percentage from 1% to 15% of
Compensation, offset by amounts actually deferred in the applicable pay period
to the Company's Qualified Plan.

         4.02 COMPANY CONTRIBUTION. With respect to amounts contributed under
Section 4.01, the Company shall add an amount specified under 4.02(a) plus an
amount equal to the excess, if any, of 4.02(b) over 4.02(c) as follows:

         4.02(a)  For Participants who were employed by the Company prior to
                  January 1, 1995, an amount equal to x% of the lesser of (i)
                  $23,500, or (ii) the amount by which the Participant's
                  Compensation exceeds $16,500, where "x" equals the Applicable
                  Percentage determined under Section 3.05(2) of the Qualified
                  Plan for such Plan Year.

         4.02(b)  The amount equal to the matching contribution the Company
                  would make to the Qualified Plan based on the Participant's
                  Compensation for such pay period if the Participant made a
                  contribution to the Qualified Plan in the amount of (1) the
                  contributions under Section 4.01 above, plus (2) the actual
                  contributions to the Qualified Plan for that pay period.

         4.02(c)  The amount equal to the Company's actual matching contribution
                  to the Qualified Plan for such pay period.

         4.03 VESTING. A Participant shall be fully vested at all times in his
or her Deferred Compensation plus interest thereon. Vesting in Company
Contributions plus interest thereon shall occur at the same time and at the same
rate as vesting occurs for Company matching contributions to the Qualified Plan.

                                       6
<PAGE>   12

         4.04 DURATION OF ELECTION FORM. A Participant's Election Form shall
remain in effect until modified or terminated as provided in Section 4.05.
Future deferrals will be terminated automatically for any Participant who is
deemed (by the Committee) to no longer be eligible for participation in the
Plan.

         4.05 ELECTION TO MODIFY OR TERMINATE FUTURE CONTRIBUTIONS. A
Participant who desires to modify or terminate the amount of future Compensation
being deferred under the Plan must notify the Plan Administrator in writing on
an Election Form provided by the Plan Administrator. Elections to decrease or
terminate deferrals of future Compensation shall become effective as soon as
administratively possible. Elections to increase deferrals of future
Compensation shall become effective on January 1 of the next Plan Year.

                                       7
<PAGE>   13

                                    ARTICLE V

                       DEFERRAL ACCOUNT AND CREDITING RATE
                       -----------------------------------

         5.01 BOOKKEEPING ACCOUNT. Compensation deferred by a Participant under
Section 4.01 herein and Company Contributions under Section 4.02 herein shall be
credited to a Bookkeeping Account maintained for each Participant. Distributions
pursuant to Articles VI and VII shall be debited against the Participant's
Bookkeeping Account.

         5.02 INTEREST. Prior to any distribution of a Participant's Bookkeeping
Account Balance under Article VI herein, an amount equal to the Crediting Rate
shall be credited and compounded quarterly to a Participant's Bookkeeping
Account Balance on each Valuation Date. For purposes of this paragraph, a
Participant's Annual Deferral Amount and Company Contributions will be treated
as though they were made in two installments: (a) half at the beginning of the
applicable quarter, and (b) half at the end of the applicable quarter.
Subsequent to the commencement of distributions under Article VI herein, the
interest credited to a Participant's Bookkeeping Account Balance shall be equal
to the Crediting Rate in effect for the Plan Year during which such benefit
payments commence.

                                       8
<PAGE>   14

                                   ARTICLE VI

                                  DISTRIBUTION
                                  ------------

         6.01 DISTRIBUTION OF BOOKKEEPING ACCOUNT BALANCE. Distribution of the
value of a Participant's Bookkeeping Account Balance shall be in a lump sum or
in 60 equal monthly installments as specified on the Participant's Election
Form. If a payment form is not specified on an Election Form, a Participant's
Bookkeeping Account balance shall be distributed as a lump sum. The selection of
a lump sum or installment payments must be made on a Participant's initial
Election Form and cannot be changed for future contributions and earnings
thereon.

         6.02 FORM OF DISTRIBUTION. All distributions of a Participant's
Bookkeeping Account shall be made in cash only.

         6.03 TIMING OF DISTRIBUTION. Distributions shall commence, or be paid
in a lump sum if so elected, as soon as administratively feasible after the
Participant's Termination of Employment.

         6.04 DEATH PRIOR TO COMMENCEMENT OF BENEFIT PAYMENTS. In the event of a
Participant's death prior to the commencement of benefit payments hereunder, an
amount equal to the Participant's Bookkeeping Account Balance shall be paid to
the Participant's Beneficiary in a lump sum within 90 days after the
Participant's death.

         6.05 DEATH OF A PARTICIPANT SUBSEQUENT TO COMMENCEMENT OF INSTALLMENT
PAYMENTS. In the event of the death of a Participant subsequent to commencement
of installment payments hereunder but prior to completion of such payments,
the installments shall continue and shall be paid to the designated Beneficiary
as if the Participant had survived.

                                       9
<PAGE>   15

                                   ARTICLE VII

                        UNFORESEEABLE FINANCIAL EMERGENCY
                        ---------------------------------

         7.01 UNFORESEEABLE FINANCIAL EMERGENCY. At the request of a Participant
or at the request of any of the Participant's Beneficiaries after the
Participant's death, the Plan Administrator may, in its sole discretion,
accelerate and pay all or part of the value of a Participant's Bookkeeping
Account Balance. Accelerated distributions at the request of the Participant or
a Participant's Beneficiaries may be allowed only in the event of a financial
emergency beyond the Participant's or Beneficiary's control due to unforeseeable
circumstances and only if disallowance of a distribution would create a severe
hardship for the Participant or Beneficiary. An accelerated distribution must be
limited to only that amount necessary to relieve the financial emergency.

                                       10
<PAGE>   16

                                  ARTICLE VIII

                                   BENEFICIARY
                                   -----------

         8.01 BENEFICIARY DESIGNATION. A Participant shall designate a
Beneficiary to receive benefits under the Plan on the Election Form provided by
the Plan Administrator. If more than one Beneficiary is named, the share and/or
precedence of each Beneficiary shall be indicated. A Participant shall have the
right to change the Beneficiary by submitting to the Plan Administrator a new
Election Form.

         8.02 PROPER BENEFICIARY. If the Plan Administrator has any doubt as to
the proper Beneficiary to receive payments hereunder, the Plan Administrator
shall have the right to withhold such payments until the matter is finally
adjudicated. However, any payment made by the Plan Administrator, in good faith
and in accordance with this Plan, shall fully discharge the Company from all
further obligations with respect to that payment.

         8.03 MINOR OR INCOMPETENT BENEFICIARY. In making any payments to or for
the benefit of any minor or an incompetent Beneficiary, the Plan Administrator,
in its sole and absolute discretion, may make a distribution to a legal or
natural guardian or other relative of a minor or court appointed committee of
such incompetent. Alternatively, it may make a payment to any adult with whom
the minor or incompetent temporarily or permanently resides. The receipt by a
guardian, committee, relative or other person shall be a complete discharge to
the Company. Neither the Company nor the Plan Administrator shall have any
responsibility to see to the proper application of any payments so made.

         8.04 NO BENEFICIARY DESIGNATION. If a Participant fails to designate a
Beneficiary as provided in Section 8.01 above, or if all designated
Beneficiaries predecease the Participant or die prior to complete distribution
of the Participant's benefits, then the Participant's designated Beneficiary
shall be deemed to be his or her surviving spouse. If the Participant has no
surviving spouse, the benefits remaining under the Plan to be paid to a
Beneficiary shall be payable to the executor or personal representative of the
Participant's estate.

                                       11
<PAGE>   17

                                   ARTICLE IX

                           ADMINISTRATION OF THE PLAN
                           --------------------------

         9.01 MAJORITY VOTE. All resolutions or other actions taken by the
Committee shall be by vote of a majority of those present at a meeting at which
a majority of the members are present, or in writing by all the members at the
time in office if they act without a meeting. Such resolutions or actions shall
be confirmed in writing by a Board resolution.

         9.02 FINALITY OF DETERMINATION. Subject to the Plan, the Committee
shall, from time to time, establish rules, forms and procedures for the
administration of the Plan. Except as herein otherwise expressly provided, the
Committee shall have the exclusive right to interpret the Plan and to decide any
and all matters arising thereunder or in connection with the administration of
the Plan, and it shall endeavor to act, whether by general rules or by
particular decisions, so as not to discriminate in favor of or against any
person. The decisions, actions and records of the Committee shall be conclusive
and binding upon the Company and all persons having or claiming to have any
right or interest in or under the Plan, and cannot be overruled by a court of
law unless arbitrary or capricious.

         9.03 CERTIFICATES AND REPORTS. The members of the Committee and the
officers and directors of the Company shall be entitled to rely on all
certificates and reports made by any duly appointed accountants, and on all
opinions given by any duly appointed legal counsel, which legal counsel may be
counsel for the Company.

         9.04 INDEMNIFICATION AND EXCULPATION. The Company shall indemnify and
hold harmless each current and former member of the Committee and each current
and former member of the Board against any and all expenses and liabilities (to
the extent not indemnified under any liability insurance contract or other
indemnification agreement) which the person incurs on account of any act or
failure to act in connection with the good faith administration of the Plan.
Expenses against which a member of the Committee shall be indemnified hereunder
shall include, without limitation, the amount of any settlement or judgment,
costs, counsel fees, and related charges reasonably incurred in connection with
a claim asserted, or a proceeding brought or settlement thereof. The foregoing
right of indemnification shalt be in addition to any other rights to which any
such member

                                       12
<PAGE>   18

of the Committee may be entitled as a matter of law, but shall be conditioned
upon the person's notifying the Company of the claim of liability within 60 days
of the notice of that claim and offering the Company the right to participate in
and control the settlement and defense of the claim.

         9.05 EXPENSES. The expenses of administering the Plan shall be borne by
the Company.

         9.06 FICA AND OTHER TAXES. For each Plan Year in which an Annual
Deferral Amount is being withheld or a Company Contribution becomes vested, the
Company shall ratably withhold from that portion of the Participant's salary
that is not being deferred, the Participant's share of FICA and other employment
taxes.

                                       13
<PAGE>   19

                                    ARTICLE X

                                CLAIMS PROCEDURE
                                ----------------

         10.01 WRITTEN CLAIM. Benefits shall be paid in accordance with the
provisions of this Plan. The Participant, or a designated recipient or any other
person claiming through the Participant shall make a written request for
benefits under this Plan. This written claim shall be mailed or delivered to the
Plan Administrator. Such claim shall be reviewed by the Plan Administrator or a
delegate.

         10.02 DENIED CLAIM. If the claim is denied, in full or in part, the
Plan Administrator shall provide a written notice within ninety (90) days
setting forth the specific reasons for denial, and any additional material or
information necessary to perfect the claim, and an explanation of why such
material or information is necessary, and appropriate information and
explanation of the steps to be taken if a review of the denial is desired.

         10.03 REVIEW PROCEDURE. If the claim is denied and a review is desired,
the Participant (or Beneficiary) shall notify the Plan Administrator in writing
within sixty (60) days after receipt of the written notice of denial. In
requesting a review, the Participant or Beneficiary may request a review of
pertinent documents with regard to the benefits created under this agreement,
may submit any written issues and comments, may request an extension of time for
such written submission of issues and comments, and may request that a hearing
be held, but the decision to hold a hearing shall be within the sole discretion
of the Committee.

         10.04 COMMITTEE REVIEW. The decision on the review of the denied claim
shall be rendered by the Committee within sixty (60) days after the receipt of
the request for review (if no hearing is held) or within sixty (60) days after
the hearing if one is held. The decision shall be written and shall state the
specific reasons for the decision including reference to specific provisions of
this Plan on which the decision is based.

                                       14
<PAGE>   20

                                   ARTICLE XI

                         NATURE OF COMPANY'S OBLIGATION
                         ------------------------------

         11.01 COMPANY'S OBLIGATION. The Company's obligations under this Plan
shall be an unfunded and unsecured promise to pay. The Company shall not be
obligated under any circumstances to fund its financial obligations under this
Plan.

         11.02 CREDITOR STATUS. Any assets which the Company may acquire or set
aside to help cover its financial liabilities are and must remain general assets
of the Company subject to the claims of its creditors. Neither the Company nor
this Plan gives a Participant or Beneficiary any beneficial ownership interest
in any asset of the Company. All rights of ownership in any such assets are and
remain in the Company. All Plan Participants and Beneficiaries shall be
unsecured general creditors of the Company.

                                       15
<PAGE>   21

                                   ARTICLE XII

                                  MISCELLANEOUS
                                  -------------

         12.01 WRITTEN NOTICE. Any notice which shall be or may be given under
the Plan shall be in writing and shall be mailed by United States mail, postage
prepaid. If notice is to be given to the Company, such notice shall be addressed
to the Plan Administrator at Res-Care, Inc. If notice is to be given to the
Participant, such notice shall be sent to the Participant's last known address.

         12.02 CHANGE OF ADDRESS. Any party may, from time to time, change the
address to which notices shall be mailed by giving written notice of such new
address.

         12.03 MERGER CONSOLIDATION OR ACQUISITION. The Plan shall be binding
upon the Company, its assigns, and any successor to the Company which shall
succeed to substantially all of its assets and business through merger,
acquisition or consolidation, and upon a Participant, a Beneficiary, assigns,
heirs, executors and administrators.

         12.04 AMENDMENT AND TERMINATION. The Company retains the sole and
unilateral right to terminate, amend, modify, or supplement this Plan, in whole
or part, at any time. However, no Company action under this right shall reduce
the Bookkeeping Account of any Participant or Beneficiary not yet in payment
status or reduce benefits that are in payment status.

         12.05 EMPLOYMENT. This Plan does not provide a contract of employment
between the Company and the Participant, and the Company reserves the right to
terminate the Participant's employment for any reason, at any time,
notwithstanding the existence of this Plan.

         12.06 NON-TRANSFERABILITY. Except insofar as prohibited by applicable
law, no sale, transfer, alienation, assignment, pledge, collateralization or
attachment of any benefits under this Plan shall be valid or recognized by the
Company. Neither the Participant, spouse, or designated Beneficiary shall have
any power to hypothecate, mortgage, commute, modify, or otherwise encumber in
advance of any of the benefits payable hereunder, nor shall any of said benefits
be subject to seizure for the payment of any debts, judgments, alimony
maintenance, owed by the Participant or Beneficiary, or be transferable by
operation of law in the event of bankruptcy, insolvency, or otherwise.

                                       16
<PAGE>   22

         12.07 LEGAL FEES. All reasonable legal fees incurred by any Participant
(or former Participant) to successfully enforce valid rights under this Plan
shall be paid by the Company in addition to sums due under this Plan.

         12.08 TAX WITHHOLDING. The Company may withhold from a payment any
federal, state, or local taxes required by law to be withheld with respect to
such payment and such sum as the Company may reasonably estimate as necessary to
cover any taxes for which the Company may be liable and which may be assessed
with regard to such payment.

         12.09 ACCELERATION OF PAYMENT. The Company reserves the right to
accelerate the payment of any benefits payable under this Plan at any time
without the consent of the Participant, the Participant's estate, a
Beneficiary or any other person claiming through the Participant.

         12.10 APPLICABLE LAW. This Plan shall be governed by the laws of the
Commonwealth of Kentucky.

IN WITNESS WHEREOF, the Company has caused this instrument to be executed by its
duly authorized officer on this _______ day of December, 1995, effective as of
the 1st day of December, 1995.

RES-CARE, INC.

BY /s/ Ronald G. Geary
---------------------------
       (Title)

ATTEST:

By
   ------------------------

[SEAL]

                                       17

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00021-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00021-of-00352.parquet"}]]